We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Sealant Prevents Post-Surgical CSF Leaks

By HospiMedica staff writers
Posted on 09 Jun 2003
A new sealant serves as an adjunct to dural closure for the prevention of postsurgical cerebrospinal fluid (CSF) leaks.

Results of a clinical trial showed that the sealant was both safe and effective, with a 100% success rate in sealing the dura intraoperatively and a 96% postsurgical leak-free rate in patients meeting the criteria for the study. More...
The sealant, called DuraSeal, is the product of Confluent Surgical, Inc. (Waltham, MA, USA). The company develops products based on its platform technologies of in-situ polymerized biomaterials and associated delivery systems.

"Its distinguishing feature includes the immediate, watertight seal, even when applied in difficult-to-reach areas,” said principal investigator Professor J.A. Grotenhuis, M.D., Ph.D., chairman of the department of neurosurgery at the University Medical Center in Nijmegan (The Netherlands). "The ability to create a consistent seal gives me a higher level of confidence in CSF-leak prevention vs fibrin glue when performing dural closure.” Dr. Grotenhuis is recognized for his expertise in neurosurgery and experience with surgical sealants.

The results of the clinical trial were presented at a symposium of the American Association of Neurological Surgeons in San Diego (CA, USA).




Related Links:
Confluent Surgical, Inc.

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.